103928,0,Admission,O
103928,0,Date,O
103928,0,:,O
103928,0,[,O
103928,0,*,O
103928,0,*,O
103928,0,2153-9-18,O
103928,0,*,O
103928,0,*,O
103928,0,],O
103928,0,Discharge,O
103928,0,Date,O
103928,0,:,O
103928,0,[,O
103928,0,*,O
103928,0,*,O
103928,0,2153-10-4,O
103928,0,*,O
103928,0,*,O
103928,0,],O
103928,0,Date,O
103928,0,of,O
103928,0,Birth,O
103928,0,:,O
103928,0,[,O
103928,0,*,O
103928,0,*,O
103928,0,2079-3-29,O
103928,0,*,O
103928,0,*,O
103928,0,],O
103928,0,Sex,O
103928,0,:,O
103928,0,M,O
103928,0,Service,O
103928,0,:,O
103928,0,MEDICINE,O
103928,0,Allergies,O
103928,0,:,O
103928,0,Percocet,B-Drug
103928,0,/,O
103928,0,Codeine,B-Drug
103928,0,/,O
103928,0,Demerol,B-Drug
103928,0,/,O
103928,0,Nafcillin,B-Drug
103928,0,Attending,O
103928,0,:,O
103928,0,[,O
103928,0,*,O
103928,0,*,O
103928,0,First,O
103928,0,Name3,O
103928,0,(,O
103928,0,LF,O
103928,0,),O
103928,0,689,O
103928,0,*,O
103928,0,*,O
103928,0,],O
103928,0,Chief,O
103928,0,Complaint,O
103928,0,:,O
103928,0,Cellulitis,O
103928,0,",",O
103928,0,troponin,O
103928,0,leak,O
103928,0,Major,O
103928,0,Surgical,O
103928,0,or,O
103928,0,Invasive,O
103928,0,Procedure,O
103928,0,:,O
103928,0,Bedside,O
103928,0,debridement,O
103928,0,of,O
103928,0,eschar,O
103928,0,on,O
103928,0,right,O
103928,0,foot,O
103928,0,History,O
103928,0,of,O
103928,0,Present,O
103928,0,Illness,O
103928,0,:,O
103928,0,74,O
103928,0,yo,O
103928,0,M,O
103928,0,with,O
103928,0,MM,O
103928,0,including,O
103928,0,PVD,O
103928,0,",",O
103928,0,DM,O
103928,0,",",O
103928,0,HTN,O
103928,0,",",O
103928,0,CAD,O
103928,0,",",O
103928,0,CRI,O
103928,1,transferred,O
103928,1,from,O
103928,1,NWH,O
103928,1,for,O
103928,1,cellulitis/LE,O
103928,1,pain,O
103928,1,because,O
103928,1,pt,O
103928,1,'s,O
103928,1,podiatric,O
103928,1,surgeon,O
103928,1,is,O
103928,1,at,O
103928,1,[,O
103928,1,*,O
103928,1,*,O
103928,1,Hospital1,O
103928,1,18,O
103928,1,*,O
103928,1,*,O
103928,1,],O
103928,1,.,O
103928,1,Initally,O
103928,1,presented,O
103928,1,to,O
103928,1,NWH,O
103928,1,because,O
103928,1,of,O
103928,1,increasing,O
103928,1,right,O
103928,1,foot,O
103928,1,pain,O
103928,1,and,O
103928,1,redness,O
103928,1,.,O
103928,1,At,O
103928,1,NWH,O
103928,1,",",O
103928,1,found,O
103928,1,to,O
103928,1,have,O
103928,1,EKG,O
103928,1,changes,O
103928,1,with,O
103928,1,STD,O
103928,1,in,O
103928,1,V2-V4,O
103928,1,",",O
103928,1,though,O
103928,1,patient,O
103928,1,was,O
103928,1,asymptomatic,O
103928,1,and,O
103928,1,said,O
103928,1,he,O
103928,1,never,O
103928,1,had,O
103928,1,chest,O
103928,1,pain,O
103928,1,.,O
103928,1,Unclear,O
103928,1,if,O
103928,1,he,O
103928,1,received,O
103928,1,abx,O
103928,1,from,O
103928,1,there,O
103928,1,per,O
103928,1,records,O
103928,1,available,O
103928,1,.,O
103928,1,Patient,O
103928,1,was,O
103928,1,transferred,O
103928,1,here,O
103928,1,for,O
103928,1,further,O
103928,1,management,O
103928,1,.,O
103928,2,.,O
103928,2,Of,O
103928,2,note,O
103928,2,",",O
103928,2,patient,O
103928,2,was,O
103928,2,recently,O
103928,2,hospitalized,O
103928,2,[,O
103928,2,*,O
103928,2,*,O
103928,2,Date,O
103928,2,range,O
103928,2,(,O
103928,2,1,O
103928,2,),O
103928,2,91344,O
103928,2,*,O
103928,2,*,O
103928,2,],O
103928,2,in,O
103928,2,the,O
103928,2,ICU,O
103928,2,at,O
103928,2,NWH,O
103928,2,when,O
103928,2,he,O
103928,2,was,O
103928,2,found,O
103928,2,at,O
103928,2,home,O
103928,2,unresponsive,O
103928,2,-,O
103928,2,was,O
103928,2,hypoglycemic,O
103928,2,and,O
103928,2,in,O
103928,2,ARF,O
103928,2,.,O
103928,2,Patient,O
103928,2,states,O
103928,2,he,O
103928,2,does,O
103928,2,not,O
103928,2,remember,O
103928,2,'anything,O
103928,2,',O
103928,2,about,O
103928,2,that,O
103928,2,hospital,O
103928,2,stay,O
103928,2,",",O
103928,2,the,O
103928,2,medications,O
103928,2,he,O
103928,2,was,O
103928,2,on,O
103928,2,or,O
103928,2,any,O
103928,2,events,O
103928,2,that,O
103928,2,occurred,O
103928,2,then,O
103928,2,.,O
103928,2,Per,O
103928,2,report,O
103928,2,",",O
103928,2,he,O
103928,2,was,O
103928,2,discharged,O
103928,2,on,O
103928,2,lovenox,B-Drug
103928,2,for,O
103928,2,DVT,B-Reason
103928,2,but,O
103928,2,when,O
103928,2,NWH,O
103928,2,ED,O
103928,2,was,O
103928,2,[,O
103928,2,*,O
103928,2,*,O
103928,2,Name,O
103928,2,(,O
103928,2,NI,O
103928,2,),O
103928,2,653,O
103928,2,*,O
103928,2,*,O
103928,2,],O
103928,2,",",O
103928,2,records,O
103928,2,there,O
103928,2,indicated,O
103928,2,that,O
103928,2,he,O
103928,2,was,O
103928,2,started,O
103928,2,on,O
103928,2,Lovenox,B-Drug
103928,3,ppx,B-Reason
103928,3,because,O
103928,3,he,O
103928,3,was,O
103928,3,immobile,O
103928,3,and,O
103928,3,was,O
103928,3,supposed,O
103928,3,to,O
103928,3,continue,O
103928,3,taking,O
103928,3,it,O
103928,3,until,O
103928,3,he,O
103928,3,was,O
103928,3,able,O
103928,3,to,O
103928,3,consistently,O
103928,3,walk,O
103928,3,>,O
103928,3,100,O
103928,3,feet,O
103928,3,.,O
103928,3,Unclear,O
103928,3,if,O
103928,3,patient,O
103928,3,has,O
103928,3,been,O
103928,3,administering,O
103928,3,the,O
103928,3,lovenox,B-Drug
103928,3,himself,O
103928,3,as,O
103928,3,he,O
103928,3,stated,O
103928,3,that,O
103928,3,he,O
103928,3,no,O
103928,3,longer,O
103928,3,gives,O
103928,3,himself,O
103928,3,insulin,B-Drug
103928,3,because,O
103928,3,'it,O
103928,3,'s,O
103928,3,just,O
103928,3,too,O
103928,3,complicated,O
103928,3,',O
103928,3,.,O
103928,3,.,O
103928,3,On,O
103928,3,past,O
103928,3,hospitalization,O
103928,3,at,O
103928,3,NWH,O
103928,3,",",O
103928,3,also,O
103928,3,had,O
103928,3,a,O
103928,3,troponin,O
103928,3,has,O
103928,3,high,O
103928,3,as,O
103928,3,8.8,O
103928,3,thought,O
103928,3,be,O
103928,3,due,O
103928,3,to,O
103928,3,demand,B-Reason
103928,3,ischemia,I-Reason
103928,3,in,I-Reason
103928,3,the,I-Reason
103928,3,setting,I-Reason
103928,3,of,I-Reason
103928,3,hypoglycemia,I-Reason
103928,3,.,O
103928,4,During,O
103928,4,that,O
103928,4,admission,O
103928,4,",",O
103928,4,he,O
103928,4,never,O
103928,4,had,O
103928,4,chest,O
103928,4,pain,O
103928,4,and,O
103928,4,a,O
103928,4,stable,O
103928,4,percent,O
103928,4,MB,O
103928,4,fraction,O
103928,4,at,O
103928,4,0.7,O
103928,4,.,O
103928,4,He,O
103928,4,was,O
103928,4,started,O
103928,4,on,O
103928,4,aspirin,B-Drug
103928,4,",",O
103928,4,beta,B-Drug
103928,4,blocker,I-Drug
103928,4,and,O
103928,4,statin,B-Drug
103928,4,.,O
103928,4,An,O
103928,4,ACEi,B-Drug
103928,4,was,O
103928,4,held,O
103928,4,due,O
103928,4,to,O
103928,4,intolerance,B-ADE
103928,4,in,O
103928,4,the,O
103928,4,past,O
103928,4,.,O
103928,4,.,O
103928,4,In,O
103928,4,the,O
103928,4,ED,O
103928,4,here,O
103928,4,VS,O
103928,4,:,O
103928,4,AF,O
103928,4,",",O
103928,4,hr:67,O
103928,4,",",O
103928,4,bp:130/70,O
103928,4,",",O
103928,4,rr:16,O
103928,4,98,O
103928,4,%,O
103928,4,on,O
103928,4,RA,O
103928,4,.,O
103928,4,Received,O
103928,4,fentanyl,B-Drug
103928,4,for,O
103928,4,pain,B-Reason
103928,4,",",O
103928,4,cards,O
103928,4,and,O
103928,4,vascular,O
103928,4,were,O
103928,4,c/s,O
103928,4,.,O
103928,4,Blood,O
103928,4,cx,O
103928,4,were,O
103928,4,drawn,O
103928,4,.,O
103928,4,Vascular,O
103928,4,recommended,O
103928,4,vanc,B-Drug
103928,4,/,O
103928,4,zosyn,B-Drug
103928,4,given,O
103928,4,their,O
103928,4,concern,O
103928,4,for,O
103928,4,osteo,O
103928,4,which,O
103928,4,he,O
103928,4,received,O
103928,4,.,O
103928,5,He,O
103928,5,received,O
103928,5,50mg,O
103928,5,iv,O
103928,5,fentanyl,B-Drug
103928,5,for,O
103928,5,pain,B-Reason
103928,5,.,O
103928,5,.,O
103928,5,Upon,O
103928,5,transfer,O
103928,5,to,O
103928,5,the,O
103928,5,floor,O
103928,5,",",O
103928,5,patient,O
103928,5,c/o,O
103928,5,of,O
103928,5,persistent,O
103928,5,right,O
103928,5,foot,O
103928,5,pain,O
103928,5,.,O
103928,5,Denies,O
103928,5,fever,O
103928,5,or,O
103928,5,chills,O
103928,5,",",O
103928,5,CP,O
103928,5,",",O
103928,5,SOB,O
103928,5,",",O
103928,5,N/V/D,O
103928,5,",",O
103928,5,constipation,O
103928,5,",",O
103928,5,HA,O
103928,5,or,O
103928,5,vision,O
103928,5,changes,O
103928,5,.,O
103928,5,.,O
103928,5,The,O
103928,5,patient,O
103928,5,is,O
103928,5,not,O
103928,5,a,O
103928,5,competent,O
103928,5,historian,O
103928,5,.,O
103928,5,On,O
103928,5,review,O
103928,5,of,O
103928,5,systems,O
103928,5,",",O
103928,5,he,O
103928,5,denies,O
103928,5,any,O
103928,5,prior,O
103928,5,history,O
103928,5,of,O
103928,5,stroke,O
103928,5,",",O
103928,5,TIA,O
103928,5,",",O
103928,5,deep,O
103928,5,venous,O
103928,5,thrombosis,O
103928,5,",",O
103928,5,pulmonary,O
103928,5,embolism,O
103928,5,",",O
103928,5,bleeding,O
103928,5,at,O
103928,5,the,O
103928,5,time,O
103928,5,of,O
103928,5,surgery,O
103928,5,",",O
103928,5,myalgias,O
103928,5,",",O
103928,5,joint,O
103928,5,pains,O
103928,5,",",O
103928,5,cough,O
103928,5,",",O
103928,5,hemoptysis,O
103928,5,",",O
103928,5,black,O
103928,5,stools,O
103928,5,or,O
103928,5,red,O
103928,5,stools,O
103928,5,.,O
103928,6,He,O
103928,6,denies,O
103928,6,recent,O
103928,6,fevers,O
103928,6,",",O
103928,6,chills,O
103928,6,or,O
103928,6,rigors,O
103928,6,.,O
103928,6,He,O
103928,6,denies,O
103928,6,exertional,O
103928,6,buttock,O
103928,6,or,O
103928,6,calf,O
103928,6,pain,O
103928,6,.,O
103928,6,All,O
103928,6,of,O
103928,6,the,O
103928,6,other,O
103928,6,review,O
103928,6,of,O
103928,6,systems,O
103928,6,per,O
103928,6,HPI,O
103928,6,.,O
103928,6,.,O
103928,6,Cardiac,O
103928,6,review,O
103928,6,of,O
103928,6,systems,O
103928,6,is,O
103928,6,notable,O
103928,6,for,O
103928,6,absence,O
103928,6,of,O
103928,6,chest,O
103928,6,pain,O
103928,6,",",O
103928,6,dyspnea,O
103928,6,on,O
103928,6,exertion,O
103928,6,",",O
103928,6,paroxysmal,O
103928,6,nocturnal,O
103928,6,dyspnea,O
103928,6,",",O
103928,6,orthopnea,O
103928,6,",",O
103928,6,ankle,O
103928,6,edema,O
103928,6,",",O
103928,6,palpitations,O
103928,6,",",O
103928,6,syncope,O
103928,6,or,O
103928,6,presyncope,O
103928,6,.,O
103928,6,Past,O
103928,6,Medical,O
103928,6,History,O
103928,6,:,O
103928,6,1,O
103928,6,.,O
103928,6,CARDIAC,O
103928,6,RISK,O
103928,6,FACTORS,O
103928,6,:,O
103928,6,(,O
103928,6,+,O
103928,6,),O
103928,6,Diabetes,O
103928,6,",",O
103928,6,(,O
103928,6,+,O
103928,6,),O
103928,6,Dyslipidemia,O
103928,6,",",O
103928,6,(,O
103928,6,+,O
103928,6,),O
103928,6,HTN,O
103928,6,2,O
103928,6,.,O
103928,7,CARDIAC,O
103928,7,HISTORY,O
103928,7,:,O
103928,7,-CABG,O
103928,7,:,O
103928,7,[,O
103928,7,*,O
103928,7,*,O
103928,7,2137,O
103928,7,*,O
103928,7,*,O
103928,7,],O
103928,7,LIMA-,O
103928,7,>,O
103928,7,LAD,O
103928,7,.,O
103928,7,SVG-,O
103928,7,>,O
103928,7,dRCA,O
103928,7,and,O
103928,7,SVG-,O
103928,7,>,O
103928,7,D1/OM,O
103928,7,.,O
103928,7,-PERCUTANEOUS,O
103928,7,CORONARY,O
103928,7,INTERVENTIONS,O
103928,7,:,O
103928,7,[,O
103928,7,*,O
103928,7,*,O
103928,7,2150,O
103928,7,*,O
103928,7,*,O
103928,7,],O
103928,7,(,O
103928,7,no,O
103928,7,report,O
103928,7,available,O
103928,7,),O
103928,7,",",O
103928,7,[,O
103928,7,*,O
103928,7,*,O
103928,7,2147,O
103928,7,*,O
103928,7,*,O
103928,7,],O
103928,7,:,O
103928,7,3VD,O
103928,7,",",O
103928,7,patent,O
103928,7,LIMA,O
103928,7,--,O
103928,7,>,O
103928,7,LAD,O
103928,7,",",O
103928,7,patnet,O
103928,7,SVG,O
103928,7,--,O
103928,7,>,O
103928,7,dRCA,O
103928,7,and,O
103928,7,D1/OM,O
103928,7,",",O
103928,7,severe,O
103928,7,native,O
103928,7,vessel,O
103928,7,disease,O
103928,7,.,O
103928,7,-PACING/ICD,O
103928,7,:,O
103928,7,None,O
103928,7,.,O
103928,7,3,O
103928,7,.,O
103928,8,OTHER,O
103928,8,PAST,O
103928,8,MEDICAL,O
103928,8,HISTORY,O
103928,8,:,O
103928,8,Per,O
103928,8,OMR,O
103928,8,notes,O
103928,8,",",O
103928,8,patient,O
103928,8,states,O
103928,8,he,O
103928,8,does,O
103928,8,not,O
103928,8,know,O
103928,8,his,O
103928,8,full,O
103928,8,medical,O
103928,8,history,O
103928,8,PVD,O
103928,8,CAD,O
103928,8,s/p,O
103928,8,MI,O
103928,8,in,O
103928,8,',O
103928,8,[,O
103928,8,*,O
103928,8,*,O
103928,8,49,O
103928,8,*,O
103928,8,*,O
103928,8,],O
103928,8,HTN,O
103928,8,Hyperlipidemia,O
103928,8,DM2,B-Reason
103928,8,on,O
103928,8,Insulin,B-Drug
103928,8,Diastolic,O
103928,8,CHF,O
103928,8,CRI,O
103928,8,(,O
103928,8,baseline,O
103928,8,1.8-2,O
103928,8,),O
103928,8,h/o,O
103928,8,GI,O
103928,8,bleed,O
103928,8,Bladder,O
103928,8,carcinoma,O
103928,8,Cervical,O
103928,8,stenosis,O
103928,8,Anemia,O
103928,8,Gastroparesis,O
103928,8,.,O
103928,8,PAST,O
103928,8,SURGICAL,O
103928,8,HISTORY,O
103928,8,:,O
103928,8,-,O
103928,8,Debridement,O
103928,8,of,O
103928,8,osteomyelitis,O
103928,8,with,O
103928,8,L.,O
103928,8,5th,O
103928,8,metatarsal,O
103928,8,head,O
103928,8,resection,O
103928,8,[,O
103928,8,*,O
103928,8,*,O
103928,8,2153-4-19,O
103928,8,*,O
103928,8,*,O
103928,8,],O
103928,8,-,O
103928,8,L,O
103928,8,CFA,O
103928,8,to,O
103928,8,BK,O
103928,8,[,O
103928,8,*,O
103928,8,*,O
103928,8,Doctor,O
103928,8,Last,O
103928,8,Name,O
103928,8,*,O
103928,8,*,O
103928,8,],O
103928,8,bypass,O
103928,8,with,O
103928,8,left,O
103928,8,arm,O
103928,8,vein,O
103928,8,[,O
103928,8,*,O
103928,8,*,O
103928,8,9-27,O
103928,8,*,O
103928,8,*,O
103928,9,],O
103928,9,-,O
103928,9,L4-5,O
103928,9,laminectomies,O
103928,9,bilat,O
103928,9,w/,O
103928,9,resection,O
103928,9,of,O
103928,9,large,O
103928,9,disk,O
103928,9,herniation,O
103928,9,[,O
103928,9,*,O
103928,9,*,O
103928,9,4-24,O
103928,9,*,O
103928,9,*,O
103928,9,],O
103928,9,-,O
103928,9,R,O
103928,9,2nd,O
103928,9,second,O
103928,9,toe,O
103928,9,amp,O
103928,9,[,O
103928,9,*,O
103928,9,*,O
103928,9,5-24,O
103928,9,*,O
103928,9,*,O
103928,9,],O
103928,9,-,O
103928,9,R,O
103928,9,CFA,O
103928,9,to,O
103928,9,AK,O
103928,9,[,O
103928,9,*,O
103928,9,*,O
103928,9,Doctor,O
103928,9,Last,O
103928,9,Name,O
103928,9,*,O
103928,9,*,O
103928,9,],O
103928,9,bypass,O
103928,9,using,O
103928,9,[,O
103928,9,*,O
103928,9,*,O
103928,9,Doctor,O
103928,9,Last,O
103928,9,Name,O
103928,9,4726,O
103928,9,*,O
103928,9,*,O
103928,9,],O
103928,9,-Tex,O
103928,9,[,O
103928,9,*,O
103928,9,*,O
103928,9,4-23,O
103928,9,*,O
103928,9,*,O
103928,9,],O
103928,9,-,O
103928,9,L,O
103928,9,CEA,O
103928,9,[,O
103928,9,*,O
103928,9,*,O
103928,9,2-/2140,O
103928,9,*,O
103928,9,*,O
103928,9,],O
103928,9,",",O
103928,9,4,O
103928,9,vessel,O
103928,9,CABG,O
103928,9,[,O
103928,9,*,O
103928,9,*,O
103928,9,1-/2138,O
103928,9,*,O
103928,9,*,O
103928,9,],O
103928,9,-,O
103928,9,Aorta-bifemoral,O
103928,9,bypass,O
103928,9,at,O
103928,9,NWH,O
103928,9,in,O
103928,9,[,O
103928,9,*,O
103928,9,*,O
103928,9,2147,O
103928,9,*,O
103928,9,*,O
103928,9,],O
103928,9,?,O
103928,10,Social,O
103928,10,History,O
103928,10,:,O
103928,10,HISTORY,O
103928,10,:,O
103928,10,Unwilling,O
103928,10,to,O
103928,10,give,O
103928,10,.,O
103928,10,Per,O
103928,10,prior,O
103928,10,records,O
103928,10,",",O
103928,10,married,O
103928,10,twice,O
103928,10,",",O
103928,10,but,O
103928,10,recently,O
103928,10,separated,O
103928,10,.,O
103928,10,He,O
103928,10,has,O
103928,10,two,O
103928,10,children,O
103928,10,.,O
103928,10,H/o,O
103928,10,EtOH,O
103928,10,abuse,O
103928,10,in,O
103928,10,AA,O
103928,10,35,O
103928,10,yrs,O
103928,10,;,O
103928,10,tobacco,O
103928,10,45,O
103928,10,pack,O
103928,10,year,O
103928,10,history,O
103928,10,Family,O
103928,10,History,O
103928,10,:,O
103928,10,Non-contributory,O
103928,10,Physical,O
103928,10,Exam,O
103928,10,:,O
103928,10,ADMISSION,O
103928,10,PHYSICAL,O
103928,10,EXAMINATION,O
103928,10,:,O
103928,10,VS,O
103928,10,:,O
103928,10,T=97.9,O
103928,10,BP=140/60,O
103928,10,HR=72,O
103928,10,RR=20,O
103928,10,O2,B-Drug
103928,10,sat=93,O
103928,10,on,O
103928,10,2L,O
103928,10,%,O
103928,10,GENERAL,O
103928,10,:,O
103928,10,elderly,O
103928,10,male,O
103928,10,lying,O
103928,10,in,O
103928,10,bed,O
103928,10,.,O
103928,10,Oriented,O
103928,10,x3,O
103928,10,.,O
103928,10,Mood,O
103928,10,appropriate,O
103928,10,.,O
103928,10,HEENT,O
103928,10,:,O
103928,10,NCAT,O
103928,10,.,O
103928,11,Sclera,O
103928,11,anicteric,O
103928,11,.,O
103928,11,PERRL,O
103928,11,",",O
103928,11,EOMI,O
103928,11,.,O
103928,11,dry,O
103928,11,mmm,O
103928,11,.,O
103928,11,Poor,O
103928,11,dentition,O
103928,11,NECK,O
103928,11,:,O
103928,11,Supple,O
103928,11,.,O
103928,11,No,O
103928,11,JVD,O
103928,11,.,O
103928,11,CARDIAC,O
103928,11,:,O
103928,11,RRR,O
103928,11,.,O
103928,11,s1/s2,O
103928,11,.,O
103928,11,III/VI,O
103928,11,systolic,O
103928,11,murmur,O
103928,11,heard,O
103928,11,best,O
103928,11,at,O
103928,11,LLSB,O
103928,11,.,O
103928,11,LUNGS,O
103928,11,:,O
103928,11,clear,O
103928,11,anteriorly,O
103928,11,.,O
103928,11,patient,O
103928,11,unwilling,O
103928,11,to,O
103928,11,fully,O
103928,11,sit,O
103928,11,up,O
103928,11,for,O
103928,11,posterior,O
103928,11,thorax,O
103928,11,exam,O
103928,11,",",O
103928,11,so,O
103928,11,limited,O
103928,11,.,O
103928,11,Heard,O
103928,11,scattered,O
103928,11,wheezes,O
103928,11,and,O
103928,11,crackles,O
103928,11,at,O
103928,11,bases,O
103928,11,posteriorly,O
103928,11,.,O
103928,11,ABDOMEN,O
103928,11,:,O
103928,11,Soft,O
103928,11,",",O
103928,11,NTND,O
103928,11,.,O
103928,11,+bs,O
103928,11,EXTREMITIES,O
103928,11,:,O
103928,11,chronic,O
103928,11,venous,O
103928,11,statis,O
103928,11,changes,O
103928,11,bilaterlly,O
103928,11,.,O
103928,12,warm,O
103928,12,to,O
103928,12,touch,O
103928,12,",",O
103928,12,DP,O
103928,12,pulses,O
103928,12,dopplerable,O
103928,12,.,O
103928,12,RLE,O
103928,12,:,O
103928,12,2,O
103928,12,eshcars,O
103928,12,-,O
103928,12,one,O
103928,12,on,O
103928,12,medial,O
103928,12,aspect,O
103928,12,of,O
103928,12,foot,O
103928,12,and,O
103928,12,one,O
103928,12,on,O
103928,12,plantar,O
103928,12,aspect,O
103928,12,of,O
103928,12,foot,O
103928,12,.,O
103928,12,Area,O
103928,12,of,O
103928,12,erythema,O
103928,12,on,O
103928,12,anterior/medial,O
103928,12,aspect,O
103928,12,of,O
103928,12,foot,O
103928,12,with,O
103928,12,increased,O
103928,12,warmth,O
103928,12,.,O
103928,12,?,O
103928,12,collection,O
103928,12,under,O
103928,12,foot,O
103928,12,?,O
103928,12,SKIN,O
103928,12,:,O
103928,12,as,O
103928,12,above,O
103928,12,Pertinent,O
103928,12,Results,O
103928,12,:,O
103928,12,Admission,O
103928,12,laboratories,O
103928,12,:,O
103928,12,COMPLETE,O
103928,12,BLOOD,O
103928,12,COUNT,O
103928,12,(,O
103928,12,[,O
103928,12,*,O
103928,12,*,O
103928,12,9-18,O
103928,12,*,O
103928,12,*,O
103928,12,],O
103928,12,),O
103928,12,WBC,O
103928,12,:,O
103928,12,9.2,O
103928,12,RBC,O
103928,12,:,O
103928,12,3.45,O
103928,12,*,O
103928,12,Hgb,O
103928,12,:,O
103928,12,8.3,O
103928,12,*,O
103928,12,#,O
103928,12,Hct:27.6,O
103928,12,*,O
103928,12,MCV:80,O
103928,12,*,O
103928,12,MCH:23.9,O
103928,12,*,O
103928,12,MCHC:30.0,O
103928,12,*,O
103928,12,RDW:24.4,O
103928,12,*,O
103928,12,Plt,O
103928,12,Ct,O
103928,12,:,O
103928,12,300,O
103928,12,DIFFERENTIAL,O
103928,12,Neuts,O
103928,12,87.1,O
103928,12,*,O
103928,12,Bands,O
103928,12,Lymphs,O
103928,12,6.3,O
103928,12,*,O
103928,13,Monos,O
103928,13,4.8,O
103928,13,Eos,O
103928,13,1.4,O
103928,13,Baso,O
103928,13,0.5,O
103928,13,[,O
103928,13,*,O
103928,13,*,O
103928,13,2153-9-18,O
103928,13,*,O
103928,13,*,O
103928,13,],O
103928,13,07:01PM,O
103928,13,BASIC,O
103928,13,COAGULATION,O
103928,13,(,O
103928,13,PT,O
103928,13,",",O
103928,13,PTT,O
103928,13,",",O
103928,13,PLT,O
103928,13,",",O
103928,13,INR,O
103928,13,),O
103928,13,PT,O
103928,13,15.0,O
103928,13,*,O
103928,13,PTT,O
103928,13,41.8,O
103928,13,*,O
103928,13,Plt,O
103928,13,Ct,O
103928,13,INR,O
103928,13,(,O
103928,13,PT,O
103928,13,),O
103928,13,1.3,O
103928,13,*,O
103928,13,Chemistry,O
103928,13,RENAL,O
103928,13,&,O
103928,13,GLUCOSE,O
103928,13,Glucose,O
103928,13,278,O
103928,13,*,O
103928,13,UreaN,O
103928,13,69,O
103928,13,*,O
103928,13,Creat,O
103928,13,2.0,O
103928,13,*,O
103928,13,Na,O
103928,13,132,O
103928,13,*,O
103928,13,K,O
103928,13,4.6,O
103928,13,Cl,O
103928,13,98,O
103928,13,HCO3,O
103928,13,22,O
103928,13,EKG,O
103928,13,(,O
103928,13,[,O
103928,13,*,O
103928,13,*,O
103928,13,9-20,O
103928,13,*,O
103928,13,*,O
103928,13,],O
103928,13,),O
103928,13,:,O
103928,13,Sinus,O
103928,13,rhythm,O
103928,13,.,O
103928,13,Right,O
103928,13,axis,O
103928,13,deviation,O
103928,13,.,O
103928,14,Incomplete,O
103928,14,right,O
103928,14,bundle,O
103928,14,branch,O
103928,14,block,O
103928,14,.,O
103928,14,One,O
103928,14,to,O
103928,14,two,O
103928,14,millimeter,O
103928,14,downsloping,O
103928,14,ST,O
103928,14,segment,O
103928,14,depression,O
103928,14,in,O
103928,14,the,O
103928,14,anterior,O
103928,14,leads,O
103928,14,extending,O
103928,14,from,O
103928,14,leads,O
103928,14,V3-V6,O
103928,14,.,O
103928,14,Consider,O
103928,14,myocardial,O
103928,14,ischemia,O
103928,14,.,O
103928,14,Compared,O
103928,14,to,O
103928,14,the,O
103928,14,previous,O
103928,14,tracing,O
103928,14,of,O
103928,14,[,O
103928,14,*,O
103928,14,*,O
103928,14,2153-9-19,O
103928,14,*,O
103928,14,*,O
103928,14,],O
103928,14,the,O
103928,14,ST-T,O
103928,14,wave,O
103928,14,changes,O
103928,14,are,O
103928,14,pretty,O
103928,14,similar,O
103928,14,except,O
103928,14,that,O
103928,14,the,O
103928,14,lead,O
103928,14,placement,O
103928,14,is,O
103928,14,slightly,O
103928,14,different,O
103928,14,.,O
103928,14,Rate,O
103928,14,PR,O
103928,14,QRS,O
103928,14,QT/QTc,O
103928,14,P,O
103928,14,QRS,O
103928,14,T,O
103928,14,72,O
103928,14,126,O
103928,14,114,O
103928,14,440/461,O
103928,14,71,O
103928,14,121,O
103928,14,113,O
103928,14,WOUND,O
103928,14,CULTURE,O
103928,14,(,O
103928,14,Final,O
103928,14,[,O
103928,14,*,O
103928,14,*,O
103928,14,2153-9-25,O
103928,14,*,O
103928,14,*,O
103928,14,],O
103928,14,),O
103928,14,:,O
103928,14,KLEBSIELLA,O
103928,14,OXYTOCA,O
103928,14,.,O
103928,15,SPARSE,O
103928,15,GROWTH,O
103928,15,.,O
103928,15,STAPH,O
103928,15,AUREUS,O
103928,15,COAG,O
103928,15,+,O
103928,15,.,O
103928,15,SPARSE,O
103928,15,GROWTH,O
103928,15,.,O
103928,15,Oxacillin,B-Drug
103928,15,RESISTANT,O
103928,15,Staphylococci,O
103928,15,MUST,O
103928,15,be,O
103928,15,reported,O
103928,15,as,O
103928,15,also,O
103928,15,RESISTANT,O
103928,15,to,O
103928,15,other,O
103928,15,penicillins,B-Drug
103928,15,",",O
103928,15,cephalosporins,O
103928,15,",",O
103928,15,carbacephems,B-Drug
103928,15,",",O
103928,15,carbapenems,B-Drug
103928,15,",",O
103928,15,and,O
103928,15,beta-lactamase,B-Drug
103928,15,inhibitor,I-Drug
103928,15,combinations,I-Drug
103928,15,.,O
103928,15,Rifampin,B-Drug
103928,15,should,O
103928,15,not,O
103928,15,be,O
103928,15,used,O
103928,15,alone,O
103928,15,for,O
103928,15,therapy,O
103928,15,.,O
103928,15,Please,O
103928,15,contact,O
103928,15,the,O
103928,15,Microbiology,O
103928,15,Laboratory,O
103928,15,(,O
103928,15,[,O
103928,15,*,O
103928,15,*,O
103928,15,6-/2450,O
103928,15,*,O
103928,15,*,O
103928,15,],O
103928,15,),O
103928,15,immediately,O
103928,15,if,O
103928,15,sensitivity,O
103928,15,to,O
103928,15,clindamycin,B-Drug
103928,15,is,O
103928,15,required,O
103928,15,on,O
103928,15,this,O
103928,15,patient,O
103928,15,'s,O
103928,15,isolate,O
103928,15,.,O
103928,15,SENSITIVITIES,O
103928,15,:,O
103928,15,MIC,O
103928,15,expressed,O
103928,15,in,O
103928,15,MCG/ML,O
103928,15,_________________________________________________________,O
103928,15,KLEBSIELLA,O
103928,15,OXYTOCA,O
103928,15,|,O
103928,15,STAPH,O
103928,15,AUREUS,O
103928,15,COAG,O
103928,15,+,O
103928,15,|,O
103928,15,|,O
103928,15,AMPICILLIN,B-Drug
103928,15,/,O
103928,15,SULBACTAM,B-Drug
103928,15,--,O
103928,15,8,O
103928,15,S,O
103928,15,CEFAZOLIN,B-Drug
103928,15,--,O
103928,15,--,O
103928,15,--,O
103928,15,--,O
103928,15,--,O
103928,15,--,O
103928,16,-,O
103928,16,8,O
103928,16,S,O
103928,16,CEFEPIME,B-Drug
103928,16,--,O
103928,16,--,O
103928,16,--,O
103928,16,--,O
103928,16,--,O
103928,16,--,O
103928,16,--,O
103928,16,<,O
103928,16,=1,O
103928,16,S,O
103928,16,CEFTAZIDIME,B-Drug
103928,16,--,O
103928,16,--,O
103928,16,--,O
103928,16,--,O
103928,16,--,O
103928,16,-,O
103928,16,<,O
103928,16,=1,O
103928,16,S,O
103928,16,CEFTRIAXONE,B-Drug
103928,16,--,O
103928,16,--,O
103928,16,--,O
103928,16,--,O
103928,16,--,O
103928,16,-,O
103928,16,<,O
103928,16,=1,O
103928,16,S,O
103928,16,CEFUROXIME,B-Drug
103928,16,--,O
103928,16,--,O
103928,16,--,O
103928,16,--,O
103928,16,--,O
103928,16,--,O
103928,16,4,O
103928,16,S,O
103928,16,CIPROFLOXACIN,B-Drug
103928,16,--,O
103928,16,--,O
103928,16,--,O
103928,16,--,O
103928,16,-,O
103928,16,<,O
103928,16,=0.25,O
103928,16,S,O
103928,16,ERYTHROMYCIN,B-Drug
103928,16,--,O
103928,16,--,O
103928,16,--,O
103928,16,--,O
103928,16,--,O
103928,16,=,O
103928,16,>,O
103928,16,8,O
103928,16,R,O
103928,16,GENTAMICIN,O
103928,16,--,O
103928,16,--,O
103928,16,--,O
103928,16,--,O
103928,16,--,O
103928,16,--,O
103928,16,<,O
103928,16,=1,O
103928,16,S,O
103928,16,<,O
103928,16,=0.5,O
103928,16,S,O
103928,16,LEVOFLOXACIN,B-Drug
103928,16,--,O
103928,16,--,O
103928,16,--,O
103928,16,--,O
103928,16,--,O
103928,16,=,O
103928,16,>,O
103928,16,8,O
103928,16,R,O
103928,16,MEROPENEM,B-Drug
103928,16,--,O
103928,16,--,O
103928,16,--,O
103928,16,--,O
103928,16,--,O
103928,16,--,O
103928,16,-,O
103928,16,<,O
103928,16,=0.25,O
103928,16,S,O
103928,16,OXACILLIN,B-Drug
103928,16,--,O
103928,16,--,O
103928,16,--,O
103928,17,--,O
103928,17,--,O
103928,17,--,O
103928,17,-,O
103928,17,=,O
103928,17,>,O
103928,17,4,O
103928,17,R,O
103928,17,PIPERACILLIN,B-Drug
103928,17,/TAZO,O
103928,17,--,O
103928,17,--,O
103928,17,-,O
103928,17,<,O
103928,17,=4,O
103928,17,S,O
103928,17,RIFAMPIN,B-Drug
103928,17,--,O
103928,17,--,O
103928,17,--,O
103928,17,--,O
103928,17,--,O
103928,17,--,O
103928,17,--,O
103928,17,<,O
103928,17,=0.5,O
103928,17,S,O
103928,17,TETRACYCLINE,B-Drug
103928,17,--,O
103928,17,--,O
103928,17,--,O
103928,17,--,O
103928,17,--,O
103928,17,<,O
103928,17,=1,O
103928,17,S,O
103928,17,TOBRAMYCIN,B-Drug
103928,17,--,O
103928,17,--,O
103928,17,--,O
103928,17,--,O
103928,17,--,O
103928,17,--,O
103928,17,<,O
103928,17,=1,O
103928,17,S,O
103928,17,TRIMETHOPRIM,B-Drug
103928,17,/SULFA,O
103928,17,--,O
103928,17,--,O
103928,17,<,O
103928,17,=1,O
103928,17,S,O
103928,17,<,O
103928,17,=0.5,O
103928,17,S,O
103928,17,VANCOMYCIN,B-Drug
103928,17,--,O
103928,17,--,O
103928,17,--,O
103928,17,--,O
103928,17,--,O
103928,17,--,O
103928,17,<,O
103928,17,=1,O
103928,17,S,O
103928,17,ANAEROBIC,O
103928,17,CULTURE,O
103928,17,(,O
103928,17,Final,O
103928,17,[,O
103928,17,*,O
103928,17,*,O
103928,17,2153-9-24,O
103928,17,*,O
103928,17,*,O
103928,17,],O
103928,17,),O
103928,17,:,O
103928,17,NO,O
103928,17,ANAEROBES,O
103928,17,ISOLATED,O
103928,17,.,O
103928,18,Imaging,O
103928,18,:,O
103928,18,Xray,O
103928,18,of,O
103928,18,right,O
103928,18,foot,O
103928,18,(,O
103928,18,[,O
103928,18,*,O
103928,18,*,O
103928,18,9-19,O
103928,18,*,O
103928,18,*,O
103928,18,],O
103928,18,),O
103928,18,:,O
103928,18,IMPRESSION,O
103928,18,:,O
103928,18,1,O
103928,18,.,O
103928,18,Erosive,O
103928,18,bony,O
103928,18,destructions,O
103928,18,at,O
103928,18,the,O
103928,18,first,O
103928,18,distal,O
103928,18,phalanx,O
103928,18,and,O
103928,18,at,O
103928,18,the,O
103928,18,stump,O
103928,18,of,O
103928,18,the,O
103928,18,second,O
103928,18,proximal,O
103928,18,phalanx,O
103928,18,consistent,O
103928,18,with,O
103928,18,osteomyelitis,O
103928,18,.,O
103928,18,2,O
103928,18,.,O
103928,18,Severe,O
103928,18,degenerative,O
103928,18,changes,O
103928,18,in,O
103928,18,the,O
103928,18,tarsometatarsal,O
103928,18,joints,O
103928,18,and,O
103928,18,fracture,O
103928,18,at,O
103928,18,the,O
103928,18,3rd,O
103928,18,metatarsal,O
103928,18,",",O
103928,18,suggesting,O
103928,18,early,O
103928,18,Charcot,O
103928,18,joint,O
103928,18,disease,O
103928,18,.,O
103928,18,3,O
103928,18,.,O
103928,18,Significant,O
103928,18,small,O
103928,18,vessel,O
103928,18,disease,O
103928,18,.,O
103928,18,2D-ECHOCARDIOGRAM,O
103928,18,(,O
103928,18,[,O
103928,18,*,O
103928,18,*,O
103928,18,9-20,O
103928,18,*,O
103928,18,*,O
103928,18,],O
103928,18,),O
103928,18,:,O
103928,18,The,O
103928,18,left,O
103928,18,atrium,O
103928,18,is,O
103928,18,mildly,O
103928,18,dilated,O
103928,18,.,O
103928,19,The,O
103928,19,right,O
103928,19,atrium,O
103928,19,is,O
103928,19,markedly,O
103928,19,dilated,O
103928,19,.,O
103928,19,Left,O
103928,19,ventricular,O
103928,19,wall,O
103928,19,thickness,O
103928,19,",",O
103928,19,cavity,O
103928,19,size,O
103928,19,and,O
103928,19,regional/global,O
103928,19,systolic,O
103928,19,function,O
103928,19,are,O
103928,19,normal,O
103928,19,(,O
103928,19,LVEF,O
103928,19,>,O
103928,19,55,O
103928,19,%,O
103928,19,),O
103928,19,.,O
103928,19,There,O
103928,19,is,O
103928,19,no,O
103928,19,left,O
103928,19,ventricular,O
103928,19,outflow,O
103928,19,obstruction,O
103928,19,at,O
103928,19,rest,O
103928,19,or,O
103928,19,with,O
103928,19,Valsalva,O
103928,19,.,O
103928,19,The,O
103928,19,right,O
103928,19,ventricular,O
103928,19,cavity,O
103928,19,is,O
103928,19,markedly,O
103928,19,dilated,O
103928,19,with,O
103928,19,moderate,O
103928,19,global,O
103928,19,free,O
103928,19,wall,O
103928,19,hypokinesis,O
103928,19,.,O
103928,19,There,O
103928,19,is,O
103928,19,abnormal,O
103928,19,septal,O
103928,19,motion/position,O
103928,19,consistent,O
103928,19,with,O
103928,19,right,O
103928,19,ventricular,O
103928,19,pressure/volume,O
103928,19,overload,O
103928,19,.,O
103928,19,The,O
103928,19,ascending,O
103928,19,aorta,O
103928,19,is,O
103928,19,moderately,O
103928,19,dilated,O
103928,19,.,O
103928,19,The,O
103928,19,aortic,O
103928,19,valve,O
103928,19,leaflets,O
103928,19,(,O
103928,19,3,O
103928,19,),O
103928,19,are,O
103928,19,mildly,O
103928,19,thickened,O
103928,19,.,O
103928,20,There,O
103928,20,is,O
103928,20,mild,O
103928,20,aortic,O
103928,20,valve,O
103928,20,stenosis,O
103928,20,(,O
103928,20,valve,O
103928,20,area,O
103928,20,1.2-1.9cm2,O
103928,20,),O
103928,20,.,O
103928,20,Trace,O
103928,20,aortic,O
103928,20,regurgitation,O
103928,20,is,O
103928,20,seen,O
103928,20,.,O
103928,20,The,O
103928,20,mitral,O
103928,20,valve,O
103928,20,leaflets,O
103928,20,are,O
103928,20,mildly,O
103928,20,thickened,O
103928,20,.,O
103928,20,There,O
103928,20,is,O
103928,20,no,O
103928,20,mitral,O
103928,20,valve,O
103928,20,prolapse,O
103928,20,.,O
103928,20,Mild,O
103928,20,to,O
103928,20,moderate,O
103928,20,(,O
103928,20,[,O
103928,20,*,O
103928,20,*,O
103928,20,12-22,O
103928,20,*,O
103928,20,*,O
103928,20,],O
103928,20,+,O
103928,20,),O
103928,20,mitral,O
103928,20,regurgitation,O
103928,20,is,O
103928,20,seen,O
103928,20,.,O
103928,20,The,O
103928,20,tricuspid,O
103928,20,valve,O
103928,20,leaflets,O
103928,20,are,O
103928,20,mildly,O
103928,20,thickened,O
103928,20,.,O
103928,20,Moderate,O
103928,20,to,O
103928,20,severe,O
103928,20,[,O
103928,20,3+,O
103928,20,],O
103928,20,tricuspid,O
103928,20,regurgitation,O
103928,20,is,O
103928,20,seen,O
103928,20,.,O
103928,20,There,O
103928,20,is,O
103928,20,severe,O
103928,20,pulmonary,O
103928,20,artery,O
103928,20,systolic,O
103928,20,hypertension,O
103928,20,.,O
103928,21,There,O
103928,21,is,O
103928,21,no,O
103928,21,pericardial,O
103928,21,effusion,O
103928,21,.,O
103928,21,Compared,O
103928,21,with,O
103928,21,the,O
103928,21,prior,O
103928,21,study,O
103928,21,(,O
103928,21,images,O
103928,21,reviewed,O
103928,21,),O
103928,21,of,O
103928,21,[,O
103928,21,*,O
103928,21,*,O
103928,21,2151-12-16,O
103928,21,*,O
103928,21,*,O
103928,21,],O
103928,21,",",O
103928,21,the,O
103928,21,detected,O
103928,21,pulmonary,O
103928,21,hypertension,O
103928,21,has,O
103928,21,increased,O
103928,21,.,O
103928,21,There,O
103928,21,is,O
103928,21,no,O
103928,21,change,O
103928,21,in,O
103928,21,the,O
103928,21,left,O
103928,21,ventricular,O
103928,21,systolic,O
103928,21,function,O
103928,21,.,O
103928,21,ETT,O
103928,21,:,O
103928,21,[,O
103928,21,*,O
103928,21,*,O
103928,21,4-/2151,O
103928,21,*,O
103928,21,*,O
103928,21,],O
103928,21,:,O
103928,21,This,O
103928,21,72,O
103928,21,yo,O
103928,21,man,O
103928,21,with,O
103928,21,IDDM,O
103928,21,",",O
103928,21,mild,O
103928,21,AS,O
103928,21,s/p,O
103928,21,multiple,O
103928,21,cadiac,O
103928,21,interventions,O
103928,21,was,O
103928,21,referred,O
103928,21,to,O
103928,21,the,O
103928,21,lab,O
103928,21,for,O
103928,21,evaluation,O
103928,21,as,O
103928,21,a,O
103928,21,part,O
103928,21,of,O
103928,21,the,O
103928,21,Spinal,O
103928,21,Cord,O
103928,21,Stimulation,O
103928,21,study,O
103928,21,.,O
103928,22,The,O
103928,22,patient,O
103928,22,exercised,O
103928,22,for,O
103928,22,2.5,O
103928,22,minutes,O
103928,22,on,O
103928,22,a,O
103928,22,modified,O
103928,22,[,O
103928,22,*,O
103928,22,*,O
103928,22,Doctor,O
103928,22,First,O
103928,22,Name,O
103928,22,*,O
103928,22,*,O
103928,22,],O
103928,22,protocol,O
103928,22,and,O
103928,22,stopped,O
103928,22,due,O
103928,22,a,O
103928,22,marked,O
103928,22,drop,O
103928,22,in,O
103928,22,systolic,O
103928,22,blood,O
103928,22,pressure,O
103928,22,.,O
103928,22,This,O
103928,22,represents,O
103928,22,a,O
103928,22,very,O
103928,22,limited,O
103928,22,exercise,O
103928,22,tolerance,O
103928,22,for,O
103928,22,his,O
103928,22,age,O
103928,22,.,O
103928,22,The,O
103928,22,patient,O
103928,22,denied,O
103928,22,any,O
103928,22,neck,O
103928,22,",",O
103928,22,chest,O
103928,22,",",O
103928,22,arm,O
103928,22,or,O
103928,22,back,O
103928,22,discomfort,O
103928,22,throughout,O
103928,22,the,O
103928,22,study,O
103928,22,.,O
103928,22,In,O
103928,22,the,O
103928,22,setting,O
103928,22,of,O
103928,22,baseline,O
103928,22,abnormalities,O
103928,22,",",O
103928,22,an,O
103928,22,additional,O
103928,22,0.5mm,O
103928,22,of,O
103928,22,ST,O
103928,22,segment,O
103928,22,depression,O
103928,22,was,O
103928,22,noted,O
103928,22,in,O
103928,22,V4-V5,O
103928,22,at,O
103928,22,peak,O
103928,22,exercise,O
103928,22,.,O
103928,23,These,O
103928,23,changes,O
103928,23,returned,O
103928,23,to,O
103928,23,baseline,O
103928,23,by,O
103928,23,minute,O
103928,23,3,O
103928,23,post-exercise,O
103928,23,.,O
103928,23,The,O
103928,23,rhythm,O
103928,23,was,O
103928,23,sinus,O
103928,23,with,O
103928,23,a,O
103928,23,single,O
103928,23,VPB,O
103928,23,in,O
103928,23,late,O
103928,23,recovery,O
103928,23,period,O
103928,23,.,O
103928,23,Marked,O
103928,23,drop,O
103928,23,in,O
103928,23,blood,O
103928,23,pressure,O
103928,23,with,O
103928,23,exercise,O
103928,23,(,O
103928,23,136/60mmHg,O
103928,23,at,O
103928,23,rest,O
103928,23,to,O
103928,23,98/50mmHg,O
103928,23,at,O
103928,23,peak,O
103928,23,),O
103928,23,.,O
103928,23,Post-exercise,O
103928,23,hypertension,O
103928,23,was,O
103928,23,noted,O
103928,23,(,O
103928,23,172/60mmHg,O
103928,23,at,O
103928,23,10,O
103928,23,minutes,O
103928,23,of,O
103928,23,recovery,O
103928,23,),O
103928,23,.,O
103928,23,.,O
103928,23,IMPRESSION,O
103928,23,:,O
103928,23,Marked,O
103928,23,drop,O
103928,23,in,O
103928,23,blood,O
103928,23,pressure,O
103928,23,with,O
103928,23,exercise,O
103928,23,.,O
103928,23,Non-specific,O
103928,23,EKG,O
103928,23,changes,O
103928,23,without,O
103928,23,anginal,O
103928,23,type,O
103928,23,symptoms,O
103928,23,.,O
103928,23,.,O
103928,23,CARDIAC,O
103928,23,CATH,O
103928,23,:,O
103928,23,[,O
103928,23,*,O
103928,23,*,O
103928,23,2147,O
103928,23,*,O
103928,23,*,O
103928,23,],O
103928,23,:,O
103928,23,COMMENTS,O
103928,23,:,O
103928,23,1,O
103928,23,.,O
103928,24,Coronary,O
103928,24,angiography,O
103928,24,of,O
103928,24,this,O
103928,24,right,O
103928,24,dominant,O
103928,24,circulation,O
103928,24,revealed,O
103928,24,severe,O
103928,24,native,O
103928,24,three,O
103928,24,vessel,O
103928,24,disease,O
103928,24,.,O
103928,24,The,O
103928,24,LMCA,O
103928,24,had,O
103928,24,a,O
103928,24,30,O
103928,24,%,O
103928,24,narrowing,O
103928,24,.,O
103928,24,The,O
103928,24,LAD,O
103928,24,had,O
103928,24,diffuse,O
103928,24,luminal,O
103928,24,irregularities,O
103928,24,and,O
103928,24,a,O
103928,24,70,O
103928,24,%,O
103928,24,proximal,O
103928,24,stenosis,O
103928,24,.,O
103928,24,The,O
103928,24,mid,O
103928,24,vessel,O
103928,24,was,O
103928,24,diffusely,O
103928,24,diseased,O
103928,24,but,O
103928,24,the,O
103928,24,distal,O
103928,24,vessel,O
103928,24,filled,O
103928,24,via,O
103928,24,a,O
103928,24,patent,O
103928,24,LIMA-,O
103928,24,>,O
103928,24,dLAD,O
103928,24,.,O
103928,24,The,O
103928,24,LAD,O
103928,24,supplied,O
103928,24,a,O
103928,24,large,O
103928,24,S2,O
103928,24,that,O
103928,24,had,O
103928,24,an,O
103928,24,80,O
103928,24,%,O
103928,24,lesion,O
103928,24,at,O
103928,24,its,O
103928,24,ostium,O
103928,24,.,O
103928,24,The,O
103928,24,LAD,O
103928,24,supplied,O
103928,24,two,O
103928,24,moderate,O
103928,24,sized,O
103928,24,diagonal,O
103928,24,branches,O
103928,24,which,O
103928,24,had,O
103928,24,diffuse,O
103928,24,luminal,O
103928,24,irregularities,O
103928,24,.,O
103928,25,The,O
103928,25,LCX,O
103928,25,tapered,O
103928,25,quickly,O
103928,25,and,O
103928,25,was,O
103928,25,totally,O
103928,25,occluded,O
103928,25,in,O
103928,25,the,O
103928,25,proximal,O
103928,25,vessel,O
103928,25,after,O
103928,25,a,O
103928,25,small,O
103928,25,OM,O
103928,25,branch,O
103928,25,.,O
103928,25,The,O
103928,25,RCA,O
103928,25,was,O
103928,25,diffusely,O
103928,25,diseased,O
103928,25,and,O
103928,25,totally,O
103928,25,occluded,O
103928,25,proximally,O
103928,25,.,O
103928,25,2,O
103928,25,.,O
103928,25,Selective,O
103928,25,vein,O
103928,25,graft,O
103928,25,angiography,O
103928,25,revealed,O
103928,25,a,O
103928,25,widely,O
103928,25,patent,O
103928,25,SVG-,O
103928,25,>,O
103928,25,dRCA,O
103928,25,and,O
103928,25,a,O
103928,25,widely,O
103928,25,patent,O
103928,25,SVG-,O
103928,25,>,O
103928,25,D1/OM,O
103928,25,.,O
103928,25,3,O
103928,25,.,O
103928,25,Selective,O
103928,25,arterial,O
103928,25,conduit,O
103928,25,arteriography,O
103928,25,demonstrated,O
103928,25,a,O
103928,25,widely,O
103928,25,patent,O
103928,25,LIMA-,O
103928,25,>,O
103928,25,LAD,O
103928,25,.,O
103928,25,4,O
103928,25,.,O
103928,25,Resting,O
103928,25,hemodynamics,O
103928,25,revealed,O
103928,25,markedly,O
103928,25,elevated,O
103928,25,right,O
103928,25,and,O
103928,25,left,O
103928,25,ventricular,O
103928,25,filling,O
103928,25,pressures,O
103928,25,with,O
103928,25,an,O
103928,25,LVEDP,O
103928,25,of,O
103928,25,29,O
103928,25,mmHg,O
103928,25,and,O
103928,25,a,O
103928,25,mean,O
103928,25,PCW,O
103928,25,pressure,O
103928,25,of,O
103928,25,22,O
103928,25,mmHg,O
103928,25,.,O
103928,26,In,O
103928,26,addition,O
103928,26,",",O
103928,26,there,O
103928,26,were,O
103928,26,V-waves,O
103928,26,to,O
103928,26,50,O
103928,26,mmHg,O
103928,26,suggesting,O
103928,26,significant,O
103928,26,mitral,O
103928,26,regurgitation,O
103928,26,.,O
103928,26,There,O
103928,26,was,O
103928,26,evidence,O
103928,26,of,O
103928,26,moderate,O
103928,26,to,O
103928,26,severe,O
103928,26,pulmonary,O
103928,26,hypertension,O
103928,26,with,O
103928,26,PA,O
103928,26,pressures,O
103928,26,of,O
103928,26,62/21/39,O
103928,26,mmHg,O
103928,26,and,O
103928,26,a,O
103928,26,pulmonary,O
103928,26,vascular,O
103928,26,resistance,O
103928,26,of,O
103928,26,209,O
103928,26,dynes-sec/cm5,O
103928,26,.,O
103928,26,The,O
103928,26,cardiac,O
103928,26,output,O
103928,26,was,O
103928,26,preserved,O
103928,26,at,O
103928,26,6.9,O
103928,26,L/min,O
103928,26,.,O
103928,26,Note,O
103928,26,was,O
103928,26,made,O
103928,26,of,O
103928,26,a,O
103928,26,10,O
103928,26,mmHg,O
103928,26,gradient,O
103928,26,across,O
103928,26,the,O
103928,26,aortic,O
103928,26,valve,O
103928,26,.,O
103928,26,5,O
103928,26,.,O
103928,26,Left,O
103928,26,ventriculography,O
103928,26,was,O
103928,26,not,O
103928,26,performed,O
103928,26,due,O
103928,26,to,O
103928,26,the,O
103928,26,patient's,O
103928,26,underlying,O
103928,26,renal,O
103928,26,insufficiency,O
103928,26,and,O
103928,26,recent,O
103928,26,non-invasive,O
103928,26,testing,O
103928,26,documenting,O
103928,26,a,O
103928,26,preserved,O
103928,26,LV,O
103928,26,systolic,O
103928,26,function,O
103928,26,.,O
103928,27,.,O
103928,27,FINAL,O
103928,27,DIAGNOSIS,O
103928,27,:,O
103928,27,1,O
103928,27,.,O
103928,27,Severe,O
103928,27,native,O
103928,27,three,O
103928,27,vessel,O
103928,27,disease,O
103928,27,.,O
103928,27,2,O
103928,27,.,O
103928,27,Patent,O
103928,27,LIMA-,O
103928,27,>,O
103928,27,LAD,O
103928,27,.,O
103928,27,3,O
103928,27,.,O
103928,27,Patent,O
103928,27,SVG-,O
103928,27,>,O
103928,27,dRCA,O
103928,27,and,O
103928,27,SVG-,O
103928,27,>,O
103928,27,D1/OM,O
103928,27,.,O
103928,27,4,O
103928,27,.,O
103928,27,Moderate,O
103928,27,to,O
103928,27,severe,O
103928,27,left,O
103928,27,ventricular,O
103928,27,diastolic,O
103928,27,dysfunction,O
103928,27,.,O
103928,27,5,O
103928,27,.,O
103928,27,Moderate,O
103928,27,to,O
103928,27,severe,O
103928,27,pulmonary,O
103928,27,hypertension,O
103928,27,.,O
103928,27,CT,O
103928,27,head,O
103928,27,(,O
103928,27,[,O
103928,27,*,O
103928,27,*,O
103928,27,9-24,O
103928,27,*,O
103928,27,*,O
103928,27,],O
103928,27,),O
103928,27,:,O
103928,27,IMPRESSION,O
103928,27,:,O
103928,27,1,O
103928,27,.,O
103928,27,No,O
103928,27,acute,O
103928,27,intracranial,O
103928,27,process,O
103928,27,.,O
103928,27,2,O
103928,27,.,O
103928,27,Sequelae,O
103928,27,of,O
103928,27,chronic,O
103928,27,infarction,O
103928,27,involving,O
103928,27,the,O
103928,27,left,O
103928,27,parieto-occipital,O
103928,27,region,O
103928,27,.,O
103928,28,Renal,O
103928,28,U/S,O
103928,28,(,O
103928,28,[,O
103928,28,*,O
103928,28,*,O
103928,28,9-27,O
103928,28,*,O
103928,28,*,O
103928,28,],O
103928,28,),O
103928,28,:,O
103928,28,IMPRESSION,O
103928,28,:,O
103928,28,Absent,O
103928,28,diastolic,O
103928,28,flow,O
103928,28,seen,O
103928,28,in,O
103928,28,the,O
103928,28,bilateral,O
103928,28,interlobar,O
103928,28,arteries,O
103928,28,of,O
103928,28,the,O
103928,28,kidneys,O
103928,28,.,O
103928,28,The,O
103928,28,findings,O
103928,28,are,O
103928,28,nonspecific,O
103928,28,",",O
103928,28,but,O
103928,28,indicate,O
103928,28,renal,O
103928,28,parenchymal,O
103928,28,disease,O
103928,28,.,O
103928,28,There,O
103928,28,is,O
103928,28,limited,O
103928,28,evaluation,O
103928,28,of,O
103928,28,the,O
103928,28,main,O
103928,28,renal,O
103928,28,arteries,O
103928,28,",",O
103928,28,but,O
103928,28,there,O
103928,28,is,O
103928,28,no,O
103928,28,clear,O
103928,28,evidence,O
103928,28,of,O
103928,28,renal,O
103928,28,artery,O
103928,28,stenosis,O
103928,28,.,O
103928,28,There,O
103928,28,is,O
103928,28,no,O
103928,28,hydronephrosis,O
103928,28,.,O
103928,28,Brief,O
103928,28,Hospital,O
103928,28,Course,O
103928,28,:,O
103928,28,Summary,O
103928,28,:,O
103928,28,74,O
103928,28,yo,O
103928,28,M,O
103928,28,transferred,O
103928,28,from,O
103928,28,NWH,O
103928,28,with,O
103928,28,EKG,O
103928,28,changes,O
103928,28,",",O
103928,28,trop,O
103928,28,here,O
103928,28,to,O
103928,28,0.87,O
103928,28,(,O
103928,28,baseline,O
103928,28,0.2,O
103928,28,),O
103928,28,and,O
103928,28,RLE,O
103928,28,cellulitis,O
103928,28,",",O
103928,28,right,O
103928,28,foot,O
103928,28,osteomyelitis,O
103928,28,",",O
103928,28,worsening,O
103928,28,acute,O
103928,28,on,O
103928,28,chronic,O
103928,29,renal,O
103928,29,failure,O
103928,29,#,O
103928,29,Right,O
103928,29,lower,O
103928,29,extremity,O
103928,29,cellulitis,O
103928,29,and,O
103928,29,right,O
103928,29,foot,O
103928,29,osteomyelitis,O
103928,29,:,O
103928,29,The,O
103928,29,patient,O
103928,29,presented,O
103928,29,with,O
103928,29,right,O
103928,29,lower,O
103928,29,extremity,O
103928,29,cellulitis,O
103928,29,and,O
103928,29,was,O
103928,29,found,O
103928,29,to,O
103928,29,have,O
103928,29,osteomyelitis,O
103928,29,in,O
103928,29,the,O
103928,29,right,O
103928,29,foot,O
103928,29,.,O
103928,29,Vascular,O
103928,29,surgery,O
103928,29,evaluated,O
103928,29,the,O
103928,29,patient,O
103928,29,and,O
103928,29,thought,O
103928,29,that,O
103928,29,treatment,O
103928,29,for,O
103928,29,the,O
103928,29,infection,B-Reason
103928,29,and,O
103928,29,ischemia,O
103928,29,would,O
103928,29,be,O
103928,29,a,O
103928,29,below,O
103928,29,the,O
103928,29,knee,O
103928,29,amputation,O
103928,29,",",O
103928,29,though,O
103928,29,given,O
103928,29,the,O
103928,29,patient,O
103928,29,'s,O
103928,29,poor,O
103928,29,cardiac,O
103928,29,status,O
103928,29,",",O
103928,29,he,O
103928,29,would,O
103928,29,not,O
103928,29,be,O
103928,29,a,O
103928,29,good,O
103928,29,candidate,O
103928,29,for,O
103928,29,surgery,O
103928,29,.,O
103928,29,The,O
103928,29,patient,O
103928,29,was,O
103928,29,empirically,O
103928,29,started,O
103928,29,on,O
103928,29,Vancomycin,B-Drug
103928,29,and,O
103928,29,Zosyn,B-Drug
103928,29,.,O
103928,30,A,O
103928,30,wound,O
103928,30,culture,O
103928,30,grew,O
103928,30,Klebsiella,O
103928,30,oxytoca,O
103928,30,and,O
103928,30,MRSA,O
103928,30,and,O
103928,30,continued,O
103928,30,on,O
103928,30,those,O
103928,30,antibiotics,O
103928,30,.,O
103928,30,Since,O
103928,30,vascular,O
103928,30,surgery,O
103928,30,would,O
103928,30,be,O
103928,30,high,O
103928,30,risk,O
103928,30,",",O
103928,30,podiatry,O
103928,30,was,O
103928,30,consulted,O
103928,30,for,O
103928,30,local,O
103928,30,debridement,O
103928,30,.,O
103928,30,They,O
103928,30,debrided,O
103928,30,the,O
103928,30,area,O
103928,30,locally,O
103928,30,",",O
103928,30,yet,O
103928,30,erythema,O
103928,30,of,O
103928,30,the,O
103928,30,right,O
103928,30,foot,O
103928,30,existed,O
103928,30,.,O
103928,30,It,O
103928,30,remained,O
103928,30,unclear,O
103928,30,whether,O
103928,30,the,O
103928,30,erythema,O
103928,30,was,O
103928,30,due,O
103928,30,to,O
103928,30,ischemia,O
103928,30,vs.,O
103928,30,a,O
103928,30,subcutaneous,O
103928,30,abscess,O
103928,30,",",O
103928,30,so,O
103928,30,they,O
103928,30,recommended,O
103928,30,a,O
103928,30,MRI,O
103928,30,of,O
103928,30,the,O
103928,30,foot,O
103928,30,.,O
103928,30,The,O
103928,30,MRI,O
103928,30,was,O
103928,30,never,O
103928,30,performed,O
103928,30,because,O
103928,30,after,O
103928,30,discussion,O
103928,30,with,O
103928,30,the,O
103928,30,family,O
103928,30,and,O
103928,30,primary,O
103928,30,care,O
103928,30,physician,O
103928,30,",",O
103928,30,[,O
103928,30,*,O
103928,30,*,O
103928,30,Name10,O
103928,30,(,O
103928,30,NameIs,O
103928,30,),O
103928,30,*,O
103928,30,*,O
103928,30,],O
103928,30,was,O
103928,30,decided,O
103928,30,for,O
103928,30,the,O
103928,30,patient,O
103928,30,to,O
103928,30,become,O
103928,31,CMO,O
103928,31,.,O
103928,31,His,O
103928,31,antibiotics,O
103928,31,were,O
103928,31,withdrawn,O
103928,31,and,O
103928,31,wound,O
103928,31,care,O
103928,31,applied,O
103928,31,to,O
103928,31,the,O
103928,31,area,O
103928,31,.,O
103928,31,#,O
103928,31,Acute,O
103928,31,on,O
103928,31,chronic,O
103928,31,renal,O
103928,31,failure,O
103928,31,:,O
103928,31,The,O
103928,31,patient,O
103928,31,presented,O
103928,31,with,O
103928,31,a,O
103928,31,creatinine,O
103928,31,close,O
103928,31,to,O
103928,31,his,O
103928,31,baseline,O
103928,31,",",O
103928,31,however,O
103928,31,",",O
103928,31,after,O
103928,31,periods,O
103928,31,of,O
103928,31,hypotension,O
103928,31,",",O
103928,31,likely,O
103928,31,due,O
103928,31,to,O
103928,31,a,O
103928,31,peri-septic,O
103928,31,state,O
103928,31,",",O
103928,31,his,O
103928,31,creatinine,O
103928,31,starting,O
103928,31,to,O
103928,31,rise,O
103928,31,.,O
103928,31,He,O
103928,31,was,O
103928,31,given,O
103928,31,fluid,O
103928,31,boluses,O
103928,31,of,O
103928,31,500,O
103928,31,cc,O
103928,31,of,O
103928,31,normal,B-Drug
103928,31,saline,I-Drug
103928,31,as,O
103928,31,needed,O
103928,31,because,O
103928,31,his,O
103928,31,urine,O
103928,31,lytes,O
103928,31,showed,O
103928,31,a,O
103928,31,FeUrea~20-25,O
103928,31,%,O
103928,31,.,O
103928,31,Renal,O
103928,31,was,O
103928,31,consulted,O
103928,31,and,O
103928,31,thought,O
103928,31,his,O
103928,31,creatinine,O
103928,31,rise,O
103928,31,was,O
103928,31,likely,O
103928,31,due,O
103928,31,to,O
103928,31,acute,O
103928,31,tubular,O
103928,31,necrosis,O
103928,31,secondary,O
103928,31,to,O
103928,31,a,O
103928,31,pre-renal,O
103928,31,state,O
103928,31,.,O
103928,32,The,O
103928,32,patient,O
103928,32,was,O
103928,32,offered,O
103928,32,aluminium,O
103928,32,hydroxide,O
103928,32,for,O
103928,32,high,O
103928,32,phosphate,O
103928,32,levels,O
103928,32,",",O
103928,32,but,O
103928,32,the,O
103928,32,patient,O
103928,32,refused,O
103928,32,it,O
103928,32,.,O
103928,32,A,O
103928,32,renal,O
103928,32,ultrasound,O
103928,32,showed,O
103928,32,no,O
103928,32,hydronephrosis,O
103928,32,.,O
103928,32,The,O
103928,32,patient,O
103928,32,became,O
103928,32,progressively,O
103928,32,oliguric,O
103928,32,with,O
103928,32,UOP,O
103928,32,less,O
103928,32,than,O
103928,32,20,O
103928,32,cc/hour,O
103928,32,.,O
103928,32,Renal,O
103928,32,thought,O
103928,32,his,O
103928,32,kidneys,O
103928,32,would,O
103928,32,unlikely,O
103928,32,recover,O
103928,32,(,O
103928,32,his,O
103928,32,creatinine,O
103928,32,rose,O
103928,32,to,O
103928,32,5.3,O
103928,32,despite,O
103928,32,interventions,O
103928,32,),O
103928,32,.,O
103928,32,The,O
103928,32,patient,O
103928,32,and,O
103928,32,his,O
103928,32,family,O
103928,32,felt,O
103928,32,that,O
103928,32,they,O
103928,32,did,O
103928,32,not,O
103928,32,want,O
103928,32,to,O
103928,32,pursue,O
103928,32,dialysis,O
103928,32,as,O
103928,32,an,O
103928,32,option,O
103928,32,.,O
103928,32,#,O
103928,32,Increased,O
103928,32,troponins,O
103928,32,:,O
103928,32,The,O
103928,32,patient,O
103928,32,was,O
103928,32,noted,O
103928,32,to,O
103928,32,have,O
103928,32,high,O
103928,32,troponins,O
103928,32,and,O
103928,32,excentuated,O
103928,32,ST,O
103928,32,wave,O
103928,32,depressions,O
103928,32,in,O
103928,32,V3-V5,O
103928,32,.,O
103928,33,Cardiology,O
103928,33,was,O
103928,33,consulted,O
103928,33,and,O
103928,33,recommended,O
103928,33,medical,O
103928,33,management,O
103928,33,with,O
103928,33,a,O
103928,33,beta,B-Drug
103928,33,blocker,I-Drug
103928,33,",",O
103928,33,ACE,B-Drug
103928,33,inhibitor,I-Drug
103928,33,",",O
103928,33,statin,O
103928,33,",",O
103928,33,and,O
103928,33,aspirin,B-Drug
103928,33,.,O
103928,33,The,O
103928,33,patient,O
103928,33,was,O
103928,33,started,O
103928,33,on,O
103928,33,these,O
103928,33,medications,O
103928,33,",",O
103928,33,though,O
103928,33,became,O
103928,33,persistently,O
103928,33,hyperkalemic,O
103928,33,",",O
103928,33,and,O
103928,33,therefore,O
103928,33,",",O
103928,33,the,O
103928,33,ACEi,O
103928,33,was,O
103928,33,discontinued,O
103928,33,.,O
103928,33,Also,O
103928,33,",",O
103928,33,his,O
103928,33,CK,O
103928,33,and,O
103928,33,LFTs,O
103928,33,were,O
103928,33,[,O
103928,33,*,O
103928,33,*,O
103928,33,Last,O
103928,33,Name,O
103928,33,(,O
103928,33,LF,O
103928,33,),O
103928,33,28645,O
103928,33,*,O
103928,33,*,O
103928,33,],O
103928,33,",",O
103928,33,[,O
103928,33,*,O
103928,33,*,O
103928,33,First,O
103928,33,Name3,O
103928,33,(,O
103928,33,LF,O
103928,33,),O
103928,33,*,O
103928,33,*,O
103928,33,],O
103928,33,the,O
103928,33,statin,O
103928,33,dose,O
103928,33,of,O
103928,33,80,O
103928,33,mg,O
103928,33,was,O
103928,33,lowered,O
103928,33,to,O
103928,33,20,O
103928,33,mg,O
103928,33,and,O
103928,33,eventually,O
103928,33,discontinued,O
103928,33,due,O
103928,33,to,O
103928,33,persistently,O
103928,33,[,O
103928,33,*,O
103928,33,*,O
103928,33,First,O
103928,33,Name3,O
103928,33,(,O
103928,33,LF,O
103928,33,),O
103928,33,28645,O
103928,33,*,O
103928,33,*,O
103928,34,],O
103928,34,LFTs,O
103928,34,.,O
103928,34,An,O
103928,34,echocardiogram,O
103928,34,revealed,O
103928,34,no,O
103928,34,acute,O
103928,34,wall,O
103928,34,motion,O
103928,34,abnormality,O
103928,34,",",O
103928,34,though,O
103928,34,it,O
103928,34,did,O
103928,34,show,O
103928,34,worsening,O
103928,34,tricuspid,O
103928,34,regurgitation,O
103928,34,and,O
103928,34,increased,O
103928,34,pulmonary,O
103928,34,artery,O
103928,34,pressure,O
103928,34,.,O
103928,34,Throughout,O
103928,34,his,O
103928,34,stay,O
103928,34,",",O
103928,34,the,O
103928,34,patient,O
103928,34,did,O
103928,34,not,O
103928,34,have,O
103928,34,any,O
103928,34,chest,O
103928,34,pain,O
103928,34,.,O
103928,34,#,O
103928,34,Increased,O
103928,34,LFTs,O
103928,34,:,O
103928,34,The,O
103928,34,patient,O
103928,34,has,O
103928,34,a,O
103928,34,known,O
103928,34,history,O
103928,34,of,O
103928,34,alcohol,O
103928,34,abuse,O
103928,34,and,O
103928,34,increased,O
103928,34,LFTs,O
103928,34,in,O
103928,34,the,O
103928,34,past,O
103928,34,.,O
103928,34,During,O
103928,34,his,O
103928,34,peri-septic,O
103928,34,period,O
103928,34,",",O
103928,34,the,O
103928,34,patient,O
103928,34,was,O
103928,34,noted,O
103928,34,to,O
103928,34,have,O
103928,34,increased,O
103928,34,LFTs,O
103928,34,",",O
103928,34,likely,O
103928,34,multifactorial,O
103928,34,due,O
103928,34,to,O
103928,34,low,O
103928,34,perfusion,O
103928,34,to,O
103928,34,the,O
103928,34,liver,O
103928,34,and,O
103928,34,also,O
103928,34,congestion,O
103928,34,secondary,O
103928,34,to,O
103928,34,tricuspid,O
103928,34,regurgitation,O
103928,34,.,O
103928,35,The,O
103928,35,patient,O
103928,35,did,O
103928,35,not,O
103928,35,have,O
103928,35,any,O
103928,35,complaints,O
103928,35,of,O
103928,35,abdominal,O
103928,35,pain,O
103928,35,",",O
103928,35,though,O
103928,35,",",O
103928,35,he,O
103928,35,had,O
103928,35,hepatomegaly,O
103928,35,on,O
103928,35,exam,O
103928,35,.,O
103928,35,#,O
103928,35,Gastrointestinal,B-ADE
103928,35,bleed,I-ADE
103928,35,:,O
103928,35,The,O
103928,35,patient,O
103928,35,has,O
103928,35,a,O
103928,35,history,O
103928,35,of,O
103928,35,a,O
103928,35,GI,O
103928,35,bleed,O
103928,35,and,O
103928,35,was,O
103928,35,guiaic,O
103928,35,positive,O
103928,35,in,O
103928,35,the,O
103928,35,ER,O
103928,35,.,O
103928,35,In,O
103928,35,addition,O
103928,35,",",O
103928,35,he,O
103928,35,had,O
103928,35,a,O
103928,35,persistently,O
103928,35,elevated,O
103928,35,PT/PTT,O
103928,35,",",O
103928,35,likely,O
103928,35,due,O
103928,35,to,O
103928,35,either,O
103928,35,underlying,O
103928,35,liver,O
103928,35,or,O
103928,35,hematologic,O
103928,35,disease,O
103928,35,.,O
103928,35,The,O
103928,35,patient,O
103928,35,'s,O
103928,35,hematocrit,O
103928,35,remained,O
103928,35,stable,O
103928,35,until,O
103928,35,[,O
103928,35,*,O
103928,35,*,O
103928,35,9-26,O
103928,35,*,O
103928,35,*,O
103928,35,],O
103928,35,when,O
103928,35,his,O
103928,35,hematocrit,O
103928,35,dropped,O
103928,35,from,O
103928,35,29.0,O
103928,35,to,O
103928,35,25.6,O
103928,35,and,O
103928,35,was,O
103928,35,noted,O
103928,35,to,O
103928,35,have,O
103928,35,melenic,O
103928,35,stools,O
103928,35,.,O
103928,36,He,O
103928,36,continued,O
103928,36,to,O
103928,36,have,O
103928,36,melenic,O
103928,36,stools,O
103928,36,",",O
103928,36,so,O
103928,36,he,O
103928,36,was,O
103928,36,transfused,O
103928,36,one,O
103928,36,unit,O
103928,36,of,O
103928,36,blood,O
103928,36,and,O
103928,36,transferred,O
103928,36,to,O
103928,36,the,O
103928,36,MICU,O
103928,36,.,O
103928,36,His,O
103928,36,aspirin,B-Drug
103928,36,was,O
103928,36,discontinued,O
103928,36,.,O
103928,36,His,O
103928,36,hematocrit,O
103928,36,remained,O
103928,36,stable,O
103928,36,in,O
103928,36,the,O
103928,36,MICU,O
103928,36,and,O
103928,36,transferred,O
103928,36,to,O
103928,36,the,O
103928,36,floors,O
103928,36,where,O
103928,36,there,O
103928,36,were,O
103928,36,no,O
103928,36,signs,O
103928,36,of,O
103928,36,any,O
103928,36,GI,O
103928,36,bleeding,O
103928,36,.,O
103928,36,Altered,O
103928,36,mental,O
103928,36,status,O
103928,36,:,O
103928,36,The,O
103928,36,patient,O
103928,36,had,O
103928,36,periods,O
103928,36,where,O
103928,36,he,O
103928,36,had,O
103928,36,altered,O
103928,36,mental,O
103928,36,status,O
103928,36,",",O
103928,36,mostly,O
103928,36,at,O
103928,36,night,O
103928,36,.,O
103928,36,His,O
103928,36,AMS,O
103928,36,was,O
103928,36,likely,O
103928,36,multifactorial,O
103928,36,due,O
103928,36,to,O
103928,36,infection,O
103928,36,",",O
103928,36,pain,O
103928,36,and,O
103928,36,uremia,O
103928,36,.,O
103928,37,He,O
103928,37,had,O
103928,37,significant,O
103928,37,altered,O
103928,37,mental,O
103928,37,status,O
103928,37,on,O
103928,37,one,O
103928,37,day,O
103928,37,when,O
103928,37,he,O
103928,37,appeared,O
103928,37,more,O
103928,37,somnolent,O
103928,37,with,O
103928,37,respirations=10/min,O
103928,37,after,O
103928,37,a,O
103928,37,dose,O
103928,37,of,O
103928,37,Morphine,B-Drug
103928,37,2mg,O
103928,37,IV,O
103928,37,.,O
103928,37,Narcane,O
103928,37,was,O
103928,37,given,O
103928,37,with,O
103928,37,some,O
103928,37,effect,O
103928,37,.,O
103928,37,A,O
103928,37,head,O
103928,37,CT,O
103928,37,showed,O
103928,37,no,O
103928,37,acute,O
103928,37,pathology,O
103928,37,.,O
103928,37,He,O
103928,37,continued,O
103928,37,to,O
103928,37,have,O
103928,37,periods,O
103928,37,of,O
103928,37,delirium,O
103928,37,mostly,O
103928,37,at,O
103928,37,night,O
103928,37,.,O
103928,37,#,O
103928,37,Pruritis,B-ADE
103928,37,:,O
103928,37,The,O
103928,37,patient,O
103928,37,has,O
103928,37,been,O
103928,37,complaining,O
103928,37,of,O
103928,37,pruritis,O
103928,37,",",O
103928,37,especially,O
103928,37,on,O
103928,37,his,O
103928,37,back,O
103928,37,",",O
103928,37,since,O
103928,37,admission,O
103928,37,.,O
103928,37,A,O
103928,37,variety,O
103928,37,of,O
103928,37,remedies,O
103928,37,were,O
103928,37,tried,O
103928,37,for,O
103928,37,wound,O
103928,37,care,O
103928,37,.,O
103928,38,According,O
103928,38,to,O
103928,38,his,O
103928,38,son,O
103928,38,",",O
103928,38,the,O
103928,38,pruritis,O
103928,38,has,O
103928,38,been,O
103928,38,long-standing,O
103928,38,.,O
103928,38,It,O
103928,38,might,O
103928,38,be,O
103928,38,exacerbated,O
103928,38,by,O
103928,38,his,O
103928,38,renal,O
103928,38,failure,O
103928,38,.,O
103928,38,A,O
103928,38,side,O
103928,38,effect,O
103928,38,of,O
103928,38,Morphine,B-Drug
103928,38,is,O
103928,38,a,O
103928,38,possibility,O
103928,38,",",O
103928,38,but,O
103928,38,he,O
103928,38,still,O
103928,38,had,O
103928,38,the,O
103928,38,itching,B-Reason
103928,38,even,O
103928,38,before,O
103928,38,the,O
103928,38,morphine,B-Drug
103928,38,.,O
103928,38,He,O
103928,38,is,O
103928,38,being,O
103928,38,treated,O
103928,38,with,O
103928,38,skin,O
103928,38,care,O
103928,38,",",O
103928,38,sarna,B-Drug
103928,38,lotion,O
103928,38,",",O
103928,38,hydrocortisone,B-Drug
103928,38,and,O
103928,38,doxepin,B-Drug
103928,38,.,O
103928,38,Goals,O
103928,38,of,O
103928,38,care,O
103928,38,:,O
103928,38,The,O
103928,38,patient,O
103928,38,entered,O
103928,38,the,O
103928,38,hospital,O
103928,38,as,O
103928,38,full,O
103928,38,code,O
103928,38,.,O
103928,38,After,O
103928,38,the,O
103928,38,renal,O
103928,38,and,O
103928,38,GI,O
103928,38,bleeding,O
103928,38,complications,O
103928,38,from,O
103928,38,his,O
103928,38,illness,O
103928,38,",",O
103928,38,the,O
103928,38,patient,O
103928,38,and,O
103928,38,his,O
103928,38,family,O
103928,38,decided,O
103928,38,to,O
103928,38,become,O
103928,38,DNR/DNI,O
103928,38,.,O
103928,39,After,O
103928,39,a,O
103928,39,meeting,O
103928,39,with,O
103928,39,the,O
103928,39,PCP,O
103928,39,and,O
103928,39,the,O
103928,39,family,O
103928,39,",",O
103928,39,they,O
103928,39,thought,O
103928,39,the,O
103928,39,best,O
103928,39,route,O
103928,39,would,O
103928,39,be,O
103928,39,to,O
103928,39,become,O
103928,39,comfort,O
103928,39,measures,O
103928,39,only,O
103928,39,instead,O
103928,39,of,O
103928,39,pursuing,O
103928,39,dialysis,O
103928,39,and,O
103928,39,being,O
103928,39,chronically,O
103928,39,cared,O
103928,39,for,O
103928,39,in,O
103928,39,a,O
103928,39,nursing,O
103928,39,home,O
103928,39,.,O
103928,39,At,O
103928,39,first,O
103928,39,",",O
103928,39,it,O
103928,39,was,O
103928,39,thought,O
103928,39,that,O
103928,39,his,O
103928,39,beta,B-Drug
103928,39,blocker,I-Drug
103928,39,",",O
103928,39,aspirin,B-Drug
103928,39,",",O
103928,39,and,O
103928,39,antibiotics,B-Drug
103928,39,would,O
103928,39,be,O
103928,39,continued,O
103928,39,",",O
103928,39,however,O
103928,39,",",O
103928,39,after,O
103928,39,further,O
103928,39,conversation,O
103928,39,",",O
103928,39,these,O
103928,39,medications,O
103928,39,were,O
103928,39,discontinued,O
103928,39,and,O
103928,39,only,O
103928,39,palliative,O
103928,39,measures,O
103928,39,for,O
103928,39,insomnia,O
103928,39,",",O
103928,39,anxiety,O
103928,39,",",O
103928,39,pain,O
103928,39,and,O
103928,39,constipation,O
103928,39,were,O
103928,39,ordered,O
103928,39,.,O
103928,40,Medications,O
103928,40,on,O
103928,40,Admission,O
103928,40,:,O
103928,40,MEDICATIONS,O
103928,40,(,O
103928,40,from,O
103928,40,NWH,O
103928,40,D/C,O
103928,40,summary,O
103928,40,on,O
103928,40,[,O
103928,40,*,O
103928,40,*,O
103928,40,9-11,O
103928,40,*,O
103928,40,*,O
103928,40,],O
103928,40,),O
103928,40,acetaminophen,B-Drug
103928,40,1,O
103928,40,g,O
103928,40,q8hr,O
103928,40,ASA,B-Drug
103928,40,325,O
103928,40,Daily,O
103928,40,Erythropoietin,B-Drug
103928,40,4000,O
103928,40,units,O
103928,40,SC,O
103928,40,weekly,O
103928,40,Ferrous,B-Drug
103928,40,sulfate,I-Drug
103928,40,325,O
103928,40,mg,O
103928,40,Daily,O
103928,40,Furosemide,B-Drug
103928,40,40,O
103928,40,mg,O
103928,40,daily,O
103928,40,Lovenox,B-Drug
103928,40,30,O
103928,40,mg,O
103928,40,SC,O
103928,40,daily,O
103928,40,until,O
103928,40,ambulatory,O
103928,40,NPH,B-Drug
103928,40,(,O
103928,40,8,O
103928,40,units,O
103928,40,before,O
103928,40,breakfast,O
103928,40,and,O
103928,40,dinner,O
103928,40,Regular,B-Drug
103928,40,insulin,I-Drug
103928,40,(,O
103928,40,5,O
103928,40,units,O
103928,40,before,O
103928,40,breakfast,O
103928,40,and,O
103928,40,dinner,O
103928,40,Metoprolol,B-Drug
103928,40,12.5,O
103928,40,mg,O
103928,40,[,O
103928,40,*,O
103928,40,*,O
103928,40,Hospital1,O
103928,40,*,O
103928,40,*,O
103928,40,],O
103928,40,MVT,O
103928,40,daily,O
103928,40,Miralax,B-Drug
103928,40,17,O
103928,40,g,O
103928,40,Daily,O
103928,40,Nystain,B-Drug
103928,40,triamcinolone,I-Drug
103928,40,cream,O
103928,40,topically,O
103928,40,twice,O
103928,40,daily,O
103928,40,omeprazole,B-Drug
103928,40,29,O
103928,40,mg,O
103928,40,daily,O
103928,40,Sarna,B-Drug
103928,40,lotion,O
103928,40,to,O
103928,40,affected,O
103928,40,area,O
103928,40,[,O
103928,40,*,O
103928,40,*,O
103928,40,Hospital1,O
103928,40,*,O
103928,41,*,O
103928,41,],O
103928,41,senokot,B-Drug
103928,41,qHs,O
103928,41,Sertraline,B-Drug
103928,41,50,O
103928,41,mg,O
103928,41,daily,O
103928,41,simvastatin,B-Drug
103928,41,20,O
103928,41,mg,O
103928,41,daily,O
103928,41,flomax,B-Drug
103928,41,0.4,O
103928,41,mg,O
103928,41,daily,O
103928,41,Discharge,O
103928,41,Medications,O
103928,41,:,O
103928,41,1,O
103928,41,.,O
103928,41,Sertraline,B-Drug
103928,41,50,O
103928,41,mg,O
103928,41,Tablet,O
103928,41,Sig,O
103928,41,:,O
103928,41,One,O
103928,41,(,O
103928,41,1,O
103928,41,),O
103928,41,Tablet,O
103928,41,PO,O
103928,41,DAILY,O
103928,41,(,O
103928,41,Daily,O
103928,41,),O
103928,41,.,O
103928,41,2,O
103928,41,.,O
103928,41,Camphor-Menthol,B-Drug
103928,41,0.5-0.5,O
103928,41,%,O
103928,41,Lotion,O
103928,41,Sig,O
103928,41,:,O
103928,41,One,O
103928,41,(,O
103928,41,1,O
103928,41,),O
103928,41,Appl,O
103928,41,Topical,O
103928,41,QID,O
103928,41,(,O
103928,41,4,O
103928,41,times,O
103928,41,a,O
103928,41,day,O
103928,41,),O
103928,41,as,O
103928,41,needed,O
103928,41,for,O
103928,41,itching,B-Reason
103928,41,.,O
103928,41,3,O
103928,41,.,O
103928,41,Acetaminophen,B-Drug
103928,41,325,O
103928,41,mg,O
103928,41,Tablet,O
103928,41,Sig,O
103928,41,:,O
103928,41,1-2,O
103928,41,Tablets,O
103928,41,PO,O
103928,41,Q6H,O
103928,41,(,O
103928,41,every,O
103928,41,6,O
103928,41,hours,O
103928,41,),O
103928,41,as,O
103928,41,needed,O
103928,41,for,O
103928,41,fever,B-Reason
103928,41,",",O
103928,41,pain,B-Reason
103928,41,.,O
103928,42,4,O
103928,42,.,O
103928,42,Quetiapine,B-Drug
103928,42,25,O
103928,42,mg,O
103928,42,Tablet,O
103928,42,Sig,O
103928,42,:,O
103928,42,One,O
103928,42,(,O
103928,42,1,O
103928,42,),O
103928,42,Tablet,O
103928,42,PO,O
103928,42,QHS,O
103928,42,(,O
103928,42,once,O
103928,42,a,O
103928,42,day,O
103928,42,(,O
103928,42,at,O
103928,42,bedtime,O
103928,42,),O
103928,42,),O
103928,42,.,O
103928,42,5,O
103928,42,.,O
103928,42,Trazodone,B-Drug
103928,42,50,O
103928,42,mg,O
103928,42,Tablet,O
103928,42,Sig,O
103928,42,:,O
103928,42,One,O
103928,42,(,O
103928,42,1,O
103928,42,),O
103928,42,Tablet,O
103928,42,PO,O
103928,42,HS,O
103928,42,(,O
103928,42,at,O
103928,42,bedtime,O
103928,42,),O
103928,42,as,O
103928,42,needed,O
103928,42,for,O
103928,42,insomnia,B-Reason
103928,42,.,O
103928,42,6,O
103928,42,.,O
103928,42,Senna,B-Drug
103928,42,8.6,O
103928,42,mg,O
103928,42,Tablet,O
103928,42,Sig,O
103928,42,:,O
103928,42,One,O
103928,42,(,O
103928,42,1,O
103928,42,),O
103928,42,Tablet,O
103928,42,PO,O
103928,42,BID,O
103928,42,(,O
103928,42,2,O
103928,42,times,O
103928,42,a,O
103928,42,day,O
103928,42,),O
103928,42,as,O
103928,42,needed,O
103928,42,for,O
103928,42,constipation,B-Reason
103928,42,.,O
103928,42,7,O
103928,42,.,O
103928,43,Docusate,B-Drug
103928,43,Sodium,I-Drug
103928,43,100,O
103928,43,mg,O
103928,43,Capsule,O
103928,43,Sig,O
103928,43,:,O
103928,43,One,O
103928,43,(,O
103928,43,1,O
103928,43,),O
103928,43,Capsule,O
103928,43,PO,O
103928,43,BID,O
103928,43,(,O
103928,43,2,O
103928,43,times,O
103928,43,a,O
103928,43,day,O
103928,43,),O
103928,43,as,O
103928,43,needed,O
103928,43,for,O
103928,43,constipation,B-Reason
103928,43,.,O
103928,43,8,O
103928,43,.,O
103928,43,Morphine,B-Drug
103928,43,10,O
103928,43,mg/5,O
103928,43,mL,O
103928,43,Solution,O
103928,43,Sig,O
103928,43,:,O
103928,43,[,O
103928,43,*,O
103928,43,*,O
103928,43,4-29,O
103928,43,*,O
103928,43,*,O
103928,43,],O
103928,43,mL,O
103928,43,PO,O
103928,43,Q4H,O
103928,43,(,O
103928,43,every,O
103928,43,4,O
103928,43,hours,O
103928,43,),O
103928,43,as,O
103928,43,needed,O
103928,43,for,O
103928,43,pain,B-Reason
103928,43,",",O
103928,43,respiratory,B-Reason
103928,43,distress,I-Reason
103928,43,.,O
103928,43,9,O
103928,43,.,O
103928,43,Hydrocortisone,B-Drug
103928,43,2.5,O
103928,43,%,O
103928,43,Cream,O
103928,43,Sig,O
103928,43,:,O
103928,43,One,O
103928,43,(,O
103928,43,1,O
103928,43,),O
103928,43,Appl,O
103928,43,Rectal,O
103928,43,TID,O
103928,43,(,O
103928,43,3,O
103928,43,times,O
103928,43,a,O
103928,43,day,O
103928,43,),O
103928,43,as,O
103928,43,needed,O
103928,43,for,O
103928,43,itching,B-Reason
103928,43,.,O
103928,44,10,O
103928,44,.,O
103928,44,Doxepin,B-Drug
103928,44,25,O
103928,44,mg,O
103928,44,Capsule,O
103928,44,Sig,O
103928,44,:,O
103928,44,One,O
103928,44,(,O
103928,44,1,O
103928,44,),O
103928,44,Capsule,O
103928,44,PO,O
103928,44,BID,O
103928,44,(,O
103928,44,2,O
103928,44,times,O
103928,44,a,O
103928,44,day,O
103928,44,),O
103928,44,.,O
103928,44,11,O
103928,44,.,O
103928,44,Quetiapine,B-Drug
103928,44,25,O
103928,44,mg,O
103928,44,Tablet,O
103928,44,Sig,O
103928,44,:,O
103928,44,One,O
103928,44,(,O
103928,44,1,O
103928,44,),O
103928,44,Tablet,O
103928,44,PO,O
103928,44,Q6H,O
103928,44,(,O
103928,44,every,O
103928,44,6,O
103928,44,hours,O
103928,44,),O
103928,44,as,O
103928,44,needed,O
103928,44,for,O
103928,44,anxiety,B-Reason
103928,44,.,O
103928,44,12,O
103928,44,.,O
103928,44,Zofran,B-Drug
103928,44,2,O
103928,44,mg/mL,O
103928,44,Solution,O
103928,44,Sig,O
103928,44,:,O
103928,44,Four,O
103928,44,(,O
103928,44,4,O
103928,44,),O
103928,44,mg,O
103928,44,Intravenous,O
103928,44,every,O
103928,44,six,O
103928,44,(,O
103928,44,6,O
103928,44,),O
103928,44,hours,O
103928,44,as,O
103928,44,needed,O
103928,44,for,O
103928,44,nausea,B-Reason
103928,44,.,O
103928,44,Discharge,O
103928,44,Disposition,O
103928,44,:,O
103928,44,Extended,O
103928,44,Care,O
103928,44,Facility,O
103928,44,:,O
103928,44,Cape,O
103928,44,Code,O
103928,44,Nursing,O
103928,44,&,O
103928,44,Rehabilitation,O
103928,44,Center,O
103928,44,-,O
103928,44,[,O
103928,44,*,O
103928,44,*,O
103928,44,Location,O
103928,44,(,O
103928,44,un,O
103928,44,),O
103928,44,10072,O
103928,44,*,O
103928,44,*,O
103928,44,],O
103928,44,Discharge,O
103928,44,Diagnosis,O
103928,44,:,O
103928,45,Primary,O
103928,45,-cellulitis,O
103928,45,of,O
103928,45,lower,O
103928,45,extremity,O
103928,45,-osteomyelitis,O
103928,45,-coronary,O
103928,45,artery,O
103928,45,disease,O
103928,45,.,O
103928,45,Secondary,O
103928,45,-Hypotension,O
103928,45,-Type,O
103928,45,II,O
103928,45,diabetes,O
103928,45,Mellitus,O
103928,45,Discharge,O
103928,45,Condition,O
103928,45,:,O
103928,45,Stable,O
103928,45,.,O
103928,45,Patient,O
103928,45,breathing,O
103928,45,on,O
103928,45,room,O
103928,45,air,O
103928,45,.,O
103928,45,Discharge,O
103928,45,Instructions,O
103928,45,:,O
103928,45,You,O
103928,45,were,O
103928,45,transferred,O
103928,45,to,O
103928,45,the,O
103928,45,hospital,O
103928,45,with,O
103928,45,right,O
103928,45,foot,O
103928,45,cellulitis,O
103928,45,and,O
103928,45,osteomyelitis,O
103928,45,.,O
103928,45,You,O
103928,45,were,O
103928,45,started,O
103928,45,on,O
103928,45,antibiotics,O
103928,45,.,O
103928,45,Vascular,O
103928,45,surgery,O
103928,45,evaluated,O
103928,45,the,O
103928,45,foot,O
103928,45,and,O
103928,45,were,O
103928,45,cautious,O
103928,45,to,O
103928,45,pursue,O
103928,45,surgical,O
103928,45,intervention,O
103928,45,because,O
103928,45,you,O
103928,45,have,O
103928,45,a,O
103928,45,poor,O
103928,45,cardiac,O
103928,45,reserve,O
103928,45,.,O
103928,45,Podiatry,O
103928,45,evaluated,O
103928,45,you,O
103928,45,and,O
103928,45,they,O
103928,45,....,O
103928,45,.,O
103928,46,You,O
103928,46,should,O
103928,46,come,O
103928,46,back,O
103928,46,to,O
103928,46,the,O
103928,46,hospital,O
103928,46,or,O
103928,46,call,O
103928,46,your,O
103928,46,primary,O
103928,46,care,O
103928,46,doctor,O
103928,46,if,O
103928,46,you,O
103928,46,have,O
103928,46,chest,O
103928,46,pain,O
103928,46,",",O
103928,46,shortness,O
103928,46,of,O
103928,46,breath,O
103928,46,",",O
103928,46,weight,O
103928,46,gain,O
103928,46,",",O
103928,46,fevers/chills,O
103928,46,or,O
103928,46,increasing,O
103928,46,pain,O
103928,46,in,O
103928,46,your,O
103928,46,right,O
103928,46,foot,O
103928,46,.,O
103928,46,Followup,O
103928,46,Instructions,O
103928,46,:,O
103928,46,PRN,O
